Triastek, Inc.

💡 One of the highlights of Triastek’s 9th Anniversary was a special session with our co-founder and CSO, Professor Xiaoling Li! In an inspiring conversation with three young scientists, they shared ideas on how scientific creativity can guide research and experiment design, how to determine if innovations are ready for commercialization, and some thoughtful advice for young professionals navigating their careers. 🎁As a special tribute, a meaningful gift was presented to Professor Li. The design of this gift integrates the Rocket Dosage Form patented technology of Triastek's first authorized patent (US15/857,724) in the United States in 2019 and Bloom Structure Design used by T22. It’s a meaningful reminder of Triastek’s continued innovation and growth！ #Triastek #HappyBirthday #SpecialPresent #RocketDosageForm #BloomStructureDesign #3DprintedDrug #T22

In the realm of boundless innovation Each partnership ignites a spark of inspiration Where vision meets innovation The flame of inspiration blooms！ With the expectation that Triastek's innovative technology will produce "blockbuster drugs", in March 2022, our coffee space was officially named "Blockbuster" and our first latte coffee was called "The Billion Dollar Molecule". To memory our ninth anniversary and our collaboration with BioNTech SE, Blockbuster Coffee Space is excited to launch two new special drinks！#Triastek #Innovation #Inspiration #Blockbuster #Coffee #3dprinteddrug #3dprintingpharmaceuticals

👉 Truth, Responsibility, Innovation, Achievement, and Solution are the core values that define Triastek's corporate culture. ☕ A memorable highlight of our 9th Anniversary celebration was a special segment that beautifully linked these values with our Blockbuster Coffee. With each sip, we hope to inspire us with a surge of creativity and energy. Creating new dimensions! Cheers! #Triastek #HappyBirthday #CoreValue #Blockbuster #Coffee #9thAnniversary #Innovation #3Dprintingpharmaceuticals

Innovation is the cornerstone of Triastek and the driving force for its continuous progress. 🎉 We celebrated Triastek's 9th Anniversary on September 3rd in Nanjing. In the insightful talks from scientific hypotheses, in the dialogues focusing on innovation and commercialization, in the imagination of looking back on the past and weaving the future, a collision of ideas and an exchange of wisdom began. #Triastek #HappyBirthday #9thAnniversary #3DPrintingPharmaceuticals #3Dprinteddrug #innovation #drugdelivery

🎉 We celebrated Triastek's 9th Anniversary on September 3rd with immense joy and excitement, made even more special by having Professor Xiaoling Li join us in Nanjing！   Over the past nine years, we've transformed a scientific hypothesis—3D printing pharmaceuticals—into a groundbreaking technology that continues to drive innovation. As we reflect on our journey with pride, we're also eagerly looking ahead to the future. Here's to many more milestones and breakthroughs! 🚀   #Triastek #HappyBirthday #3DPrintingPharmaceuticals #3Dprinteddrug #innovation #drugdelivery

🚀 Join Our Innovative Team at Triastek! We are thrilled to announce that our Q3 recruitment is now open! At Triastek, we are pioneering the future of pharmaceuticals with our cutting-edge 3D printing technology. If you are passionate, driven, and ready to make an impact in the world of pharmaceuticals, we want to hear from you! 📍 Location: Nanjing, China/ Shanghai, China 📄 Application Channel: Submit your resume to hr@triastek.com or apply directly by scanning the QR code below. Join us at Triastek and be a part of something extraordinary! #Recruitment #Hiring #CareerOpportunities #JoinOurTeam #Triastek #3DPringtingPharmaceuticals

👇 Check out Triastek 3DP Intelligent Pharmaceuticals Video！ Based on the MED® technology, Triastek has built three pharmaceutical processes, which are named MED® process, MED&MIM process and MED&SSE process. Through continuous technological iterations, Triastek has achieved continuous and large-scale production of 3D printed drug products. We have constructed GMP compliant continuous 3D printing pharmaceutical production center with a maximum annual capacity of 75 million units in the initial continuous production line, making it the largest in the global 3D printing pharmaceuticals. This production line is dedicated to the entire process from early formulation development, small-scale clinical sample production, and key clinical drug production to commercial production, offering end-to-end technical solutions for commercial partnerships. #Triastek #3DPrintingPharmaceuticals #Pharmaceuticals #MED® #drugdevelopment #innovation

🎂 Happy 9th Anniversary, Triastek! 💖 We are filled with gratitude and would like to express our sincerest thanks to every member and collaboration partner of Triastek! From theoretical to experimental scientific exploration, and from technological advancement to industrial implementation on production lines, every step taken by Triastek has been driven by your courage, wisdom, and hard work. 🚀As we step into our 10th year, we are infused with even more energy and enthusiasm to take on new challenges and achieve greater milestones in 3D printing pharmaceuticals! #Triastek #HappyBirthday #3DPrintingPharmaceuticals #3Dprinteddrug #innovation #drugdelivery

Many thanks to Endpoints News' Senior Editor Max Gelman for covering our collaboration with BioNTech SE. We look forward to 3D printing making further breakthroughs in the biopharma industry and sharing more exciting news with our Endpoints News' readers in the future!

Thanks for 3D ADEPT (3DA)'s continued attention and support in covering our milestones, from being 2023 TCT Awards Winner to the T21 FIH and now this collaboration with BioNTech SE!